Dongkook Pharmaceutical and Medipham Sign Exclusive Domestic Distribution Agreement for Chitosan-Based Skin Booster "Madekiel"

On October 14, Dongkook Pharmaceutical announced that it has signed an exclusive domestic distribution agreement with Medipham, a medical aesthetic biomaterials company, for 'Madekiel,' a chitosan-based skin booster featuring new functional properties.

Photo of Madekiel, a chitosan-based skin booster product for which Dongkook Pharmaceutical signed a domestic distribution agreement with Medipham. Photo by Dongkook Pharmaceutical

'Madekiel' is a high-performance skin booster that combines TECA (Centella Asiatica Quantitative Extract), Dongkook Pharmaceutical's signature ingredient, with Medipham's high-purity chitosan-based LTG (Liquid-To-Gel) technology. With a differentiated mechanism of action compared to existing skin boosters, it is being recognized as a next-generation solution.

Through this exclusive domestic distribution agreement for the skin booster 'Madekiel,' Dongkook Pharmaceutical plans to further strengthen its presence in the aesthetic and dermatological medical markets.

A representative from Dongkook Pharmaceutical's medical aesthetics division stated, "'Madekiel' is not just following trends, but is a product that embodies the essence of technology based on scientific evidence," adding, "We will continue to expand our differentiated aesthetic portfolio based on functionality and safety."

Additionally, a Medipham representative commented, "As the medical aesthetics market expands, the demand for diverse medical beauty materials is increasing. We will strive to strengthen our influence not only in the domestic market but also globally by developing innovative products based on a variety of materials."

Meanwhile, Dongkook Pharmaceutical recently launched a new product, 'Kabelline,' leveraging its research and development expertise from 13 years of steady use of its HA filler 'Bellast.' The company is also expanding its lineup of medical aesthetic products, including the botulinum toxin 'Vienox' and the adhesive transparent wound dressing 'Madeca MD Cream and Lotion.' [

This content was produced with the assistance of AI translation services.